Cited by 941Trypanosoma species research and implicationsResearch on Leishmaniasis StudiesVector-borne infectious diseases

The DOI matches its Crossref record; 298 of the 300 references it cites were found in a registry or an index.

Human African trypanosomiasis

Brun, Reto, Blum, Johannes, Chappuis, Francois, Burri, Christian·2010·The Lancet

DOI 10.1016/s0140-6736(09)60829-1

Open this paper in CoChat — free account

Abstract

Human African trypanosomiasis (sleeping sickness) occurs in sub-Saharan Africa. It is caused by the protozoan parasite Trypanosoma brucei, transmitted by tsetse flies. Almost all cases are due to Trypanosoma brucei gambiense, which is indigenous to west and central Africa. Prevalence is strongly dependent on control measures, which are often neglected during periods of political instability, thus leading to resurgence. With fewer than 12 000 cases of this disabling and fatal disease reported per year, trypanosomiasis belongs to the most neglected tropical diseases. The clinical presentation is complex, and diagnosis and treatment difficult. The available drugs are old, complicated to administer, and can cause severe adverse reactions. New diagnostic methods and safe and effective drugs are urgently needed. Vector control, to reduce the number of flies in existing foci, needs to be organised on a pan-African basis. WHO has stated that if national control programmes, international organisations, research institutes, and philanthropic partners engage in concerted action, elimination of this disease might even be possible.

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(09)60829-1

Cites

298 of 298 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Polyamine metabolism and function
Pegg, A. E., & McCann, P. P. (1982) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1982.243.5.c212 · Cited by 1,661
The Genome of the African Trypanosome Trypanosoma brucei
Berriman, M., Ghedin, E., Hertz‐Fowler, C., Blandin, G., Renauld, H., Bartholomeu, D. C., Lennard, N. J., Caler, E. V., Hamlin, N. E., Haas, B. J., et al. (2005) · Science · doi:10.1126/science.1112642 · Cited by 1,634
Manson's Tropical Diseases.
(1973) · Annals of Internal Medicine · doi:10.7326/0003-4819-79-2-324_1 · Cited by 997
Comparative Genomics of Trypanosomatid Parasitic Protozoa
El-Sayed, N. M., Myler, P. J., Blandin, G., Berriman, M., Crabtree, J., Aggarwal, G., Caler, E. V., Renauld, H., Worthey, E. A., Hertz‐Fowler, C., et al. (2005) · Science · doi:10.1126/science.1112181 · Cited by 832
Kinetoplastids: related protozoan pathogens, different diseases
Stuart, K., Brun, R., Croft, S. L., Fairlamb, A. H., Gürtler, R. E., McKerrow, J., Reed, S., & Tarleton, R. L. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33945 · Cited by 618
Self-citation
A clonal theory of parasitic protozoa: the population structures of Entamoeba, Giardia, Leishmania, Naegleria, Plasmodium, Trichomonas, and Trypanosoma and their medical and taxonomical consequences.
Tibayrenc, M., Kjellberg, F., & Ayala, F. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2414 · Cited by 570
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial
Priotto, G., Kasparian, S., Mutombo, W., Ngouama, D., Ghorashian, S., Arnold, U., Ghabri, S., Baudin, E., Buard, V., Kazadi-Kyanza, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61117-x · Cited by 544
HOME OR AWAY?
Jb, B., & Gj, R. (1964) · PubMed · Cited by 507
Medical Insects and Arachnids
Lane, R. P., & Crosskey, R. W. (1993) · Springer eBooks · doi:10.1007/978-94-011-1554-4 · Cited by 488
Glossina austeni (Diptera: Glossinidae) Eradicated on the Island of Unguja, Zanzibar, Using the Sterile Insect Technique
Vreysen, M. J. B., Saleh, K. M., Ali, M. Y., Abdulla, A. M., Zhu, Z.-R., Juma, K. G., Dyck, V. A., Msangi, A. R., Mkonyi, P. A., & Feldmann, H. U. (2000) · Journal of Economic Entomology · doi:10.1603/0022-0493-93.1.123 · Cited by 477

Show all 300 references

Research works printed but not linked: 4

Bronner U. Pharmacokinetics of pentamidine. Focus on treatment of Trypanosoma gambiense sleeping sickness. PhD thesis, Karolinska Institute, 1994.
Seixas J. Investigations on the encephalopathic syndrome during melarsoprol treatment of human African trypanosomiasis. PhD thesis, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, 2004.
Chappuis, 2004, Eflornithine for the treatment of human African trypanosomiasis: practical perspectives, Dev Sante, 171, 41
African Union. Statement from the Commission of the African union to the AHP/DFID special workshop on: tsetse control—the next 100 years, Sept 9–10, 2002, Edinburgh, UK.

Sorted by citations

Items 301–400 of 941

3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis
Ferrins, L., Rahmani, R., Sykes, M. L., Jones, A. J., Avery, V. M., Teston, E., Almohaywi, B., Yin, J., Smith, J. A., Hyland, C. J. T., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.05.007 · Cited by 32
Antitumor and antiparasitic activity of novel ruthenium compounds with polycyclic aromatic ligands
Miserachs, H. G., Cipriani, M., Grau, J., Vilaseca, M., Lorenzo, J., Medeiros, A., Comini, M. A., Gambino, D., Otero, L., & Moreno, V. (2015) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2015.06.007 · Cited by 32
A targeted door-to-door strategy for sleeping sickness detection in low-prevalence settings in Côte d’Ivoire
Koffi, M., N’Djetchi, M. K., Ilboudo, H., Kaba, D., Coulibaly, B., N’Gouan, E. K., Kouakou, L., Bucheton, B., Solano, P., Courtin, F., et al. (2016) · Parasite · doi:10.1051/parasite/2016059 · Cited by 32
Transcriptomics and proteomics in human African trypanosomiasis: Current status and perspectives
Geiger, A., Simo, G., Grébaut, P., Peltier, J., Cuny, G., & Holzmüller, P. (2011) · Journal of Proteomics · doi:10.1016/j.jprot.2011.01.016 · Cited by 32
Impact of the Ebola outbreak on Trypanosoma brucei gambiense infection medical activities in coastal Guinea, 2014-2015: A retrospective analysis from the Guinean national Human African Trypanosomiasis control program
Camara, M., Ouattara, E. N., Duvignaud, A., Migliani, R., Camara, O., Léno, M., Solano, P., Bucheton, B., Camara, M., & Malvy, D. J.-M. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006060 · Cited by 32
Development and Introduction of Fexinidazole into the Global Human African Trypanosomiasis Program
Mordt, O. V., Tarral, A., & Wourgaft, N. S. (2022) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.21-1176 · Cited by 31
Virology, Epidemiology and Pathology of Glossina Hytrosavirus, and Its Control Prospects in Laboratory Colonies of the Tsetse Fly, Glossina pallidipes (Diptera; Glossinidae)
Kariithi, H. M., van Oers, M. M., Vlak, J. M., Vreysen, M. J. B., Parker, A. G., & Abd‐Alla, A. M. M. (2013) · Insects · doi:10.3390/insects4030287 · Cited by 31
Pharmacokinetics, Trypanosoma brucei gambiense Efficacy, and Time of Drug Action of DB829, a Preclinical Candidate for Treatment of Second-Stage Human African Trypanosomiasis
Wenzler, T., Yang, S., Braissant, O., Boykin, D. W., Brun, R., & Wang, M. Z. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00398-13 · Cited by 31
Self-citation
5-Fluoroimidazo[4,5- b ]pyridine Is a Privileged Fragment That Conveys Bioavailability to Potent Trypanosomal Methionyl-tRNA Synthetase Inhibitors
Zhang, Z., Koh, C. Y., Ranade, R. M., Shibata, S., Gillespie, J. R., Hulverson, M. A., Huang, W., Nguyen, J., Pendem, N., Gelb, M. H., et al. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.6b00036 · Cited by 31
Preventive Chemotherapy Versus Innovative and Intensified Disease Management in Neglected Tropical Diseases: A Distinction Whose Shelf Life Has Expired
Rosenberg, M. L., Utzinger, J., & Addiss, D. G. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004521 · Cited by 31
New N-methylpiperazinyl derivatives of bicyclic antiprotozoal compounds
Faist, J., Seebacher, W., Saf, R., Brun, R., Kaiser, M., & Weis, R. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.11.022 · Cited by 31
Self-citation
Potent and Selective Inhibition of Cysteine Proteases from Plasmodium falciparum and Trypanosoma brucei
Ehmke, V., Heindl, C., Rottmann, M., Freymond, C., Schweizer, W. B., Brun, R., Stich, A., Schirmeister, T., & Diederich, F. (2010) · ChemMedChem · doi:10.1002/cmdc.201000449 · Cited by 31
Self-citation
A Quantitative 3D Motility Analysis of Trypanosoma brucei by Use of Digital In-line Holographic Microscopy
Weiße, S., Heddergott, N., Heydt, M., Pflästerer, D., Maier, T., Haraszti, T., Grunze, M., Engstler, M., & Rosenhahn, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037296 · Cited by 31
Microfluidics-based single cell analysis reveals drug-dependent motility changes in trypanosomes
Hochstetter, A., Stellamanns, E., Deshpande, S., Uppaluri, S., Engstler, M., & Pfohl, T. (2015) · Lab on a Chip · doi:10.1039/c5lc00124b · Cited by 31
Magnetic Resonance Imaging to Assess Blood–Brain Barrier Damage in Murine Trypanosomiasis
Rodgers, J., McCabe, C., Gettinby, G., Bradley, B., Condon, B. R., & Kennedy, P. G. E. (2011) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2011.10-0487 · Cited by 31
Performance of the SD BIOLINE® HAT rapid test in various diagnostic algorithms for gambiense human African trypanosomiasis in the Democratic Republic of the Congo
Lumbala, C., Bessell, P. R., Lutumba, P. T., Baloji, S., Biéler, S., & Ndung’u, J. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180555 · Cited by 31
Trypanosomiasis, cardiomyopathy and the risk of ischemic stroke
Carod-Artal, F. J. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.33 · Cited by 30
Mutualist-Provisioned Resources Impact Vector Competency
Rio, R. V. M., Jozwick, A. K. S., Savage, A. F., Sabet, A., Vigneron, A., Wu, Y., Aksoy, S., & Weiss, B. L. (2019) · mBio · doi:10.1128/mbio.00018-19 · Cited by 33
Clinical Study on the Melarsoprol-Related Encephalopathic Syndrome: Risk Factors and HLA Association
Seixas, J., Atouguia, J., Josenando, T., Vatunga, G., Bilenge, C. M. M., Lutumba, P. T., & Burri, C. (2020) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed5010005 · Cited by 30
Self-citation
An annotated checklist of the eukaryotic parasites of humans, exclusive of fungi and algae
Mathison, B. A., & Sapp, S. G. H. (2021) · ZooKeys · doi:10.3897/zookeys.1069.67403 · Cited by 30
Vectorborne diseases in West Africa: geographic distribution and geospatial characteristics
Ратманов, П. Э., Mediannikov, O., & Raoult, D. (2013) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trt020 · Cited by 30
Syndromic Algorithms for Detection of Gambiense Human African Trypanosomiasis in South Sudan
Palmer, J. J., Surur, E. I., Goch, G. W., Mayen, M. A., Lindner, A. K., Pittet, A., Kasparian, S., Checchi, F., & Whitty, C. W. M. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002003 · Cited by 30
Immunosuppression: Cause for Failures of Vaccines against African Trypanosomiases
Tabel, H., Wei, G., & Bull, H. J. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002090 · Cited by 30
Independent Pathways Can Transduce the Life-Cycle Differentiation Signal in Trypanosoma brucei
Szöőr, B., Dyer, N. A., Ruberto, I., Acosta-Serrano, Á., & Matthews, K. R. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003689 · Cited by 30
Molecular modeling studies of bromopyrrole alkaloids as potential antimalarial compounds: a DFT approach
Flores-Sumoza, M., Márquez, E., & Mora, J. R. (2017) · Medicinal Chemistry Research · doi:10.1007/s00044-017-2107-3 · Cited by 30
Suramin binds and inhibits infection of SARS-CoV-2 through both spike protein-heparan sulfate and ACE2 receptor interactions
Kwon, P. S., Xu, S., Oh, H., Kwon, S., Rodrigues, A. L., Feroz, M. M., Fraser, K., He, P., Zhang, F., Hong, J. J., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04789-z · Cited by 30
Trypanocidal and Cytotoxic Effects of 30 Ethiopian Medicinal Plants
Nibret, E., & Wink, M. (2011) · Zeitschrift für Naturforschung C · doi:10.1515/znc-2011-11-1202 · Cited by 29
Anti-trypanosomal effects of Azadiracta indica (neem) extract on Trypanosoma brucei rhodesiense-infected mice
Ngure, R. M., Ongeri, B., Karori, S., Mwangi, W. W., Maathai, R., Kibugi, J. K., & Wachira, F. N. (2009) · DergiPark (Istanbul University) · Cited by 29
Structure-guided design of novel Trypanosoma brucei Methionyl-tRNA synthetase inhibitors
Huang, W., Zhang, Z., Barros-Álvarez, X., Koh, C. Y., Ranade, R. M., Gillespie, J. R., Creason, S. A., Shibata, S., Verlinde, C. L. M. J., Hol, W. G. J., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.10.024 · Cited by 29
Drug Screening with Genetically Encoded Fluorescent Sensors: Today and Tomorrow
Potekhina, E. S., Bass, D. Y., Kelmanson, I. V., Fetisova, E. S., Ivanenko, A. V., Belousov, V. V., & Bilan, D. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010148 · Cited by 29
Human African trypanosomiasis cases diagnosed in non-endemic countries (2011–2020)
Franco, J. R., Cecchi, G., Priotto, G., Paone, M., Ebeja, A. K., Simarro, P. P., Diarra, A., Sankara, D. P., Zhao, W., & Dagne, D. A. (2022) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0010885 · Cited by 28
Recent progress in molecular diagnosis of sleeping sickness
Deborggraeve, S., & Büscher, P. (2012) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.12.72 · Cited by 28
Synthesis and evaluation of human phosphodiesterases (PDE) 5 inhibitor analogs as trypanosomal PDE inhibitors. Part 2. Tadalafil analogs
Ochiana, S. O., Gustafson, A., Bland, N. D., Wang, C., Russo, M. J., Campbell, R. K., & Pollastri, M. P. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.01.118 · Cited by 28
The role of cytokines in the pathogenesis and staging of Trypanosoma brucei rhodesiense sleeping sickness
Kato, C. D., Matovu, E., Mugasa, C. M., Nanteza, A., & Alibu, V. P. (2016) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-016-0113-5 · Cited by 28
Chromosomal copy number variation analysis by next generation sequencing confirms ploidy stability in Trypanosoma brucei subspecies
de Almeida, L. V., dos Santos, A. C., Rodrigues-Luiz, G. F., McCulloch, R., Bartholomeu, D. C., & Reis-Cunha, J. L. (2018) · Microbial Genomics · doi:10.1099/mgen.0.000223 · Cited by 28
Direct sample injection from a syringe needle into a separation capillary
Opekar, F., & Tůma, P. (2018) · Analytica Chimica Acta · doi:10.1016/j.aca.2018.07.026 · Cited by 27
A decade of vector control activities: Progress and limitations of Chagas disease prevention in a region of Guatemala with persistent Triatoma dimidiata infestation
Juarez, J. G., Pennington, P. M., Bryan, J. P., Klein, R. E., Beard, C. B., Berganza, E., RIZZO, N. R., & Cordón‐Rosales, C. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006896 · Cited by 27
Compounds containing 2-substituted imidazole ring for treatment against human African trypanosomiasis
Samant, B. S., & Sukhthankar, M. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.12.040 · Cited by 27
Synthesis and antiprotozoal activities of benzyl phenyl ether diamidine derivatives
Patrick, D. A., Bakunov, S. A., Bakunova, S. M., Jones, S., Wenzler, T., Barszcz, T., Kumar, A., Boykin, D. W., Werbovetz, K. A., Brun, R., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.06.033 · Cited by 27
Self-citation
Effect of ivermectin on trypanosoma brucei brucei in experimentally infected mice
Udensi, U. K., & Fagbenro-Beyioku, A. (2012) · Journal of Vector Borne Diseases · doi:10.4103/0972-9062.213454 · Cited by 27
Stakeholder Narratives on Trypanosomiasis, Their Effect on Policy and the Scope for One Health
Grant, C., Anderson, N. E., & Machila, N. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004241 · Cited by 29
Drugs and Drug Resistance in African and American Trypanosomiasis
Franco, J., Scarone, L., & Comini, M. A. (2018) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2018.08.003 · Cited by 27
Knowledge, attitudes and practices about human African trypanosomiasis and their implications in designing intervention strategies for Yei county, South Sudan
Bukachi, S. A., Mumbo, A. A., Alak, A. C. D., Sebit, W., Rumunu, J. P., Biéler, S., & Ndung’u, J. M. (2018) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006826 · Cited by 27
Discovery of new S-adenosylmethionine decarboxylase inhibitors for the treatment of Human African Trypanosomiasis (HAT)
Hirth, B. H., Barker, R. H., Celatka, C. A., Klinger, J. D., Liu, H., Nare, B., Nijjar, A., Phillips, M. A., Sybertz, E. J., Willert, E. K., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.04.096 · Cited by 27
Crystal Structures of Leishmania mexicana Phosphoglycerate Mutase Suggest a One-Metal Mechanism and a New Enzyme Subclass
Nowicki, M. W., Kuaprasert, B., McNae, I. W., Morgan, H. P., Harding, M. M., Michels, P. A. M., Fothergill‐Gilmore, L. A., & Walkinshaw, M. D. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.09.041 · Cited by 26
Combining paratransgenesis with SIT: impact of ionizing radiation on the DNA copy number of Sodalis glossinidius in tsetse flies
Uzel, G. D., Vooght, L. D., Parker, A., Vreysen, M. J. B., Mach, R. L., Abbeele, J. V. D., & Abd‐Alla, A. M. M. (2018) · BMC Microbiology · doi:10.1186/s12866-018-1283-8 · Cited by 26
Village-scale persistence and elimination of gambiense human African trypanosomiasis
Davis, C. N., Rock, K. S., Miaka, E. M., & Keeling, M. J. (2019) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0007838 · Cited by 26
Autochthonous Trypanosoma spp. in European Mammals: A Brief Journey amongst the Neglected Trypanosomes
Magri, A., Galuppi, R., & Fioravanti, M. (2021) · Pathogens · doi:10.3390/pathogens10030334 · Cited by 26
Molecular evidence of a Trypanosoma brucei gambiense sylvatic cycle in the human african trypanosomiasis foci of Equatorial Guinea
Cordón-Obras, C., Rodriguez, Y. F., Fernández-Martı́nez, A., Cano, J., Ndong-Mabale, N., Ncogo, P., Ndongo-Asumu, P., Aparicio, P., Navarro, M., Benito, A., et al. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00765 · Cited by 26
De Novo Genome Assembly Shows Genome Wide Similarity between Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense
Sistrom, M., Evans, B. R., Benoit, J. B., Balmer, O., Aksoy, S., & Caccone, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147660 · Cited by 26
Contribution of Innate Immune Responses towards Resistance to African Trypanosome Infections
Namangala, B. (2011) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2011.02619.x · Cited by 26
Antitrypanosomal structure–activity-relationship study of synthetic cynaropicrin derivatives
Usuki, T., Sato, M., Hara, S., Yoshimoto, Y., Kondo, R., Zimmermann, S. Y., Kaiser, M., Brun, R., Hamburger, M. O., & ADAMS, M. A. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.12.099 · Cited by 25
Self-citation
The transport of nifurtimox, an anti-trypanosomal drug, in an in vitro model of the human blood–brain barrier: Evidence for involvement of breast cancer resistance protein
Watson, C., Dogruel, M., Mihoreanu, L., Begley, D. J., Weksler, B. B., Couraud, P. O., Romero, I. A., & Thomas, S. A. (2011) · Brain Research · doi:10.1016/j.brainres.2011.11.053 · Cited by 25
Pharmacokinetic Comparison To Determine the Mechanisms Underlying the Differential Efficacies of Cationic Diamidines against First- and Second-Stage Human African Trypanosomiasis
Yang, S., Wenzler, T., Miller, P. N., Wu, H., Boykin, D. W., Brun, R., & Wang, M. Z. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02605-14 · Cited by 25
Self-citation
Crystal Structure of an Arginase-like Protein from Trypanosoma brucei That Evolved without a Binuclear Manganese Cluster
Hai, Y., Kerkhoven, E. J., Barrett, M. P., & Christianson, D. W. (2014) · Biochemistry · doi:10.1021/bi501366a · Cited by 25
Drug Discovery in Africa
Chibale, K., Masimirembwa, C. M., & Davies-Coleman, M. (2012) · Springer eBooks · doi:10.1007/978-3-642-28175-4 · Cited by 25
Pyrenocine I, a new pyrenocine analog produced by Paecilomyces sp. FKI-3573
Hashida, J., Niitsuma, M., Iwatsuki, M., Mori, M., Ishiyama, A., Namatame, M., Nishihara‐Tsukashima, A., Nonaka, K., Ui, H., Masuma, R., et al. (2010) · The Journal of Antibiotics · doi:10.1038/ja.2010.65 · Cited by 25
Dipeptidyl Enoates As Potent Rhodesain Inhibitors That Display a Dual Mode of Action
Royo, S., Rodrı́guez, S., Schirmeister, T., Kesselring, J., Kaiser, M., & González, F. V. (2015) · ChemMedChem · doi:10.1002/cmdc.201500204 · Cited by 25
Updated estimate of the duration of the meningo-encephalitic stage in gambiense human African trypanosomiasis
Checchi, F., Funk, S., Chandramohan, D., Haydon, D. T., & Chappuis, F. (2015) · BMC Research Notes · doi:10.1186/s13104-015-1244-3 · Cited by 25
Self-citation
Chemotherapy for second-stage Human African trypanosomiasis
Lutje, V., Seixas, J., & Kennedy, A. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006201.pub2 · Cited by 25
Biosynthesis of ergosterol as a relevant molecular target of metal-based antiparasitic and antifungal compounds
Scalese, G., Mosquillo, M. F., Pérez‐Díaz, L., & Gambino, D. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215608 · Cited by 24
Diagnostic Accuracy and Feasibility of Serological Tests on Filter Paper Samples for Outbreak Detection of T.b. gambiense Human African Trypanosomiasis
Hasker, E. C., Lutumba, P. T., Mumba, D., Lejon, V., Büscher, P., Kandé, V., Muyembe, J. J., Menten, J., Robays, J., & Boelaert, M. (2010) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2010.09-0735 · Cited by 24
Conceptual Shifts Needed to Understand the Dynamic Interactions of Genes, Environment, Epigenetics, Social Processes, and Behavioral Choices
Jackson, F. L. C., Niculescu, M. D., & Jackson, R. T. (2013) · American Journal of Public Health · doi:10.2105/ajph.2013.301221 · Cited by 25
Trypanosoma brucei gambiense Infections in Mice Lead to Tropism to the Reproductive Organs, and Horizontal and Vertical Transmission
Biteau, N., Asencio, C., Izotte, J., Rousseau, B., Fèvre, M., Pillay, D., & Baltz, T. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004350 · Cited by 24
Delivery of Antihuman African Trypanosomiasis Drugs Across the Blood–Brain and Blood–CSF Barriers
Sekhar, G. N., Watson, C., Fidanboylu, M., Sanderson, L., & Thomas, S. A. (2014) · Advances in pharmacology · doi:10.1016/bs.apha.2014.06.003 · Cited by 25
The Deadly Dance of B Cells with Trypanosomatids
Silva‐Barrios, S., Charpentier, T., & Stäger, S. (2017) · Trends in Parasitology · doi:10.1016/j.pt.2017.10.001 · Cited by 26
MIF-Mediated Hemodilution Promotes Pathogenic Anemia in Experimental African Trypanosomosis
Stijlemans, B., Brys, L., Korf, H., Bieniasz-Krzywiec, P., Sparkes, A., Liese, V., Leng, L., Vanbekbergen, N., Mazzone, M., Caljon, G., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005862 · Cited by 24
An Atypical Mitochondrial Carrier That Mediates Drug Action in Trypanosoma brucei
Macêdo, J. P., Burkard, G. S., Niemann, M., Barrett, M. P., Vial, H. J., Mäser, P., Roditi, I. J., Schneider, A., & Bütikofer, P. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004875 · Cited by 23
Nanotechnological approaches for pentamidine delivery
Andreana, I., Bincoletto, V., Milla, P., Dosio, F., Stella, B., & Arpicco, S. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01127-4 · Cited by 23
Isolation of Trypanosoma brucei gambiense from Cured and Relapsed Sleeping Sickness Patients and Adaptation to Laboratory Mice
Pyana, P. P., Lukusa, I. N., Ngoyi, D. M., Reet, N. V., Kaiser, M., Shamamba, S., & Büscher, P. (2011) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001025 · Cited by 23
The Changing Epidemiology of Human African Trypanosomiasis among Patients from Nonendemic Countries –1902–2012
Neuberger, A., Meltzer, E., Leshem, E., Dickstein, Y., Stienlauf, S., & Schwartz, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088647 · Cited by 23
Novel pyrrolobenzoxaboroles: Design, synthesis, and biological evaluation against Trypanosoma brucei
Wu, P., Zhang, J., Meng, Q., Nare, B., Jacobs, R. T., & Zhou, H. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.04.079 · Cited by 23
Determinants of Human African Trypanosomiasis Elimination via Paratransgenesis
Gilbert, J. A., Medlock, J., Townsend, J. P., Aksoy, S., Ndeffo-Mbah, M. L., & Galvani, A. P. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0004465 · Cited by 23
Comparative genomics of drug resistance in Trypanosoma brucei rhodesiense
Graf, F. E., Ludin, P., Arquint, C., Schmidt, R. S., Schaub, N., Renggli, C. K., Munday, J. C., Krezdorn, J., Baker, N., Horn, D., et al. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2173-6 · Cited by 23
Exploration of DAPI analogues: Synthesis, antitrypanosomal activity, DNA binding and fluorescence properties
Farahat, A. A., Kumar, A., Say, M., Wenzler, T., Brun, R., Paul, A., Wilson, W. D., & Boykin, D. W. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.01.037 · Cited by 23
Self-citation
Structural Characterization of Acidic M17 Leucine Aminopeptidases from the TriTryps and Evaluation of Their Role in Nutrient Starvation in Trypanosoma brucei
Timm, J., Valente, M., García-Caballero, D., Wilson, K. S., & González‐Pacanowska, D. (2017) · mSphere · doi:10.1128/msphere.00226-17 · Cited by 23
Transporters of Trypanosoma brucei—phylogeny, physiology, pharmacology
Schmidt, R. S., Macêdo, J. P., Steinmann, M. E., Salgado, A. G., Bütikofer, P., Sigel, E., Rentsch, D., & Mäser, P. (2017) · FEBS Journal · doi:10.1111/febs.14302 · Cited by 23
Ubiquitin-Like Modifiers: Emerging Regulators of Protozoan Parasites
Karpiyevich, M., & Artavanis‐Tsakonas, K. (2020) · Biomolecules · doi:10.3390/biom10101403 · Cited by 23
Distinct Phenotypes Caused by Mutation of MSH2 in Trypanosome Insect and Mammalian Life Cycle Forms Are Associated with Parasite Adaptation to Oxidative Stress
Grazielle-Silva, V., Zeb, T. F., Bolderson, J., Campos, P. C., Miranda, J. B., Alves, C. L., Machado, C. R., McCulloch, R., & Teixeira, S. M. R. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003870 · Cited by 23
Drug delivery systems in the treatment of African trypanosomiasis infections
Kroubi, M., Karembé, H., & Betbeder, D. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.574122 · Cited by 23
Optimization of physicochemical properties for 4-anilinoquinazoline inhibitors of trypanosome proliferation
Woodring, J. L., Bachovchin, K. A., Brady, K. G., Gallerstein, M. F., Erath, J., Tanghe, S., Leed, S. E., Rodrı́guez, A., Mensa‐Wilmot, K., Sciotti, R. J., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.10.007 · Cited by 23
Optical Systems for Point-of-care Diagnostic Instrumentation: Analysis of Imaging Performance and Cost
Pierce, M. C., Weigum, S. E., Jaslove, J. M., Richards-Kortum, R. R., & Tkaczyk, T. (2013) · Annals of Biomedical Engineering · doi:10.1007/s10439-013-0918-z · Cited by 22
Exploring the mode of action of ebselen in Trypanosoma brucei hexokinase inhibition
Joice, A. C., Harris, M. T., Kahney, E. W., Dodson, H., Maselli, A. G., Whitehead, D. C., & Morris, J. C. (2013) · International Journal for Parasitology Drugs and Drug Resistance · doi:10.1016/j.ijpddr.2013.08.002 · Cited by 22
An evolutionary analysis of trypanosomatid GP63 proteases
Ma, L., Chen, K., Meng, Q., Liu, Q., Tang, P., Hu, S., & Yu, J. (2011) · Parasitology Research · doi:10.1007/s00436-011-2348-x · Cited by 22
Identification of Mimotopes with Diagnostic Potential for Trypanosoma brucei gambiense Variant Surface Glycoproteins Using Human Antibody Fractions
Nieuwenhove, L. V., Büscher, P., Balharbi, F., Humbert, M., Dieltjens, T., Guisez, Y., & Lejon, V. (2012) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001682 · Cited by 22
Regulation of RNA binding proteins in trypanosomatid protozoan parasites
Romaniuk, M. A. (2016) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v7.i1.146 · Cited by 22
Human Leukocyte Antigen-G: A Promising Prognostic Marker of Disease Progression to Improve the Control of Human African Trypanosomiasis
Gineau, L., Courtin, D., Camara, M., Ilboudo, H., Jamonneau, V., Dias, F. C., Tokplonou, L., Milet, J., Mendonça, P. B., Castelli, E. C., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw505 · Cited by 22
The Role of Folate Transport in Antifolate Drug Action in Trypanosoma brucei
Dewar, S., Sienkiewicz, N., Ong, H. B., Wall, R. J., Horn, D., & Fairlamb, A. H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.750422 · Cited by 22
An efficient cumate-inducible system for procyclic and bloodstream form Trypanosoma brucei
Li, F., Xu, Z.-S., Aye, H. M., Brasseur, A., Lun, Z., Tan, K. S. W., & He, C. Y. (2017) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2017.04.007 · Cited by 22
A Unified Total Synthesis of the Actinoallolides, a Family of Potent Anti‐Trypanosomal Macrolides
Anketell, M. J., Sharrock, T. M., & Paterson, I. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201914042 · Cited by 22
Noninvasive Biological Samples to Detect and Diagnose Infections due to Trypanosomatidae Parasites: A Systematic Review and Meta-Analysis
Séréno, D., Akhoundi, M., Sayehmri, K., Mirzaei, A., Holzmüller, P., Lejon, V., & Waleckx, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051684 · Cited by 22
Locus-specific control of DNA resection and suppression of subtelomeric VSG recombination by HAT3 in the African trypanosome
Glover, L., & Horn, D. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku900 · Cited by 23
In Vitro and In Vivo Evaluation of 28DAP010, a Novel Diamidine for Treatment of Second-Stage African Sleeping Sickness
Wenzler, T., Yang, S., Patrick, D. A., Braissant, O., Ismail, M. A., Tidwell, R. R., Boykin, D. W., Wang, M. Z., & Brun, R. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02309-13 · Cited by 21
Self-citation
Panowamycins A and B, new antitrypanosomal isochromans produced by Streptomyces sp. K07-0010
Hashida, J., Niitsuma, M., Iwatsuki, M., Mori, M., Ishiyama, A., Namatame, M., Nishihara‐Tsukashima, A., Matsumoto, A., Ara, I., Takahashi, Y., et al. (2012) · The Journal of Antibiotics · doi:10.1038/ja.2011.139 · Cited by 21
The ins and outs of phosphatidylethanolamine synthesis in Trypanosoma brucei
Farine, L., & Bütikofer, P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.09.008 · Cited by 21
Safety, Pharmacokinetic, and Efficacy Studies of Oral DB868 in a First Stage Vervet Monkey Model of Human African Trypanosomiasis
Thuita, J. K., Wolf, K., Murilla, G. A., Liu, Q., Mutuku, J. N., Chen, Y., Bridges, A. S., Mdachi, R. E., Ismail, M. A., Ching, S. V., et al. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002230 · Cited by 21
Self-citation
Prevalence and under-detection of gambiense human African trypanosomiasis during mass screening sessions in Uganda and Sudan
Checchi, F., Cox, A. P., Chappuis, F., Priotto, G., Chandramohan, D., & Haydon, D. T. (2012) · Parasites & Vectors · doi:10.1186/1756-3305-5-157 · Cited by 21
Self-citation
A new approach to chemotherapy: drug-induced differentiation kills African trypanosomes
Wenzler, T., Burkard, G. S., Schmidt, R. S., Mäser, P., Bergner, A., Roditi, I. J., & Brun, R. (2016) · Scientific Reports · doi:10.1038/srep22451 · Cited by 21
Self-citation
Identification ofTrypanosoma bruceiAdoMetDC Inhibitors Using a High-Throughput Mass Spectrometry-Based Assay
Volkov, O. A., Cosner, C. C., Brockway, A. J., Kramer, M. L., Booker, M. L., Zhong, S., Ketcherside, A., Wei, S., Longgood, J. C., McCoy, M. K., et al. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00022 · Cited by 21
Novel triazine dimers with potent antitrypanosomal activity
Muthusamy, V., Salado, I. G., Heeres, J., Joossens, J., Lewi, P. J., Caljon, G., Maes, L. J. R. M., der Veken, P. V., & Augustyns, K. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.11.075 · Cited by 21

Authors: Brun, R., Blum, J., Chappuis, F., & Burri, C.
Affiliations: Swiss Tropical and Public Health Institute (CH)
Corresponding author: Brun, Reto
ORCID: Blum, Johannes
Burri, Christian
Venue: The Lancet
Publisher: Elsevier BV
Published: 2010-01
Volume: 375
Issue: 9709
Pages: 148-159
ISSN: 0099-5355 (ISSN-L)
0140-6736
DOI: 10.1016/s0140-6736(09)60829-1
OpenAlex: W2151877638
Cited by: 926
References: 300
Citations by year: 2026: 20 · 2025: 20 · 2024: 35 · 2023: 40 · 2022: 35 · 2021: 47 · 2020: 39 · 2019: 50 · 2018: 49 · 2017: 69 · 2016: 71 · 2015: 78 · 2014: 74 · 2013: 85 · 2012: 85
FWCI: 45.64
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: The Lancet (publishedVersion)
PubMed (publishedVersion)
Medecins Sans Frontieres Field Research (Medecins Sans Frontieres) (submittedVersion)
Topics: Health Sciences › Medicine › Epidemiology › Trypanosoma species research and implications
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Research on Leishmaniasis Studies
Life Sciences › Immunology and Microbiology › Parasitology › Vector-borne infectious diseases
Keywords: sleeping sickness, Trypanosoma brucei gambiense, tsetse flies, neglected tropical diseases, disease resurgence, political instability, vector control, disease elimination, clinical features, diagnosis, treatment, adverse drug reactions, sub-Saharan Africa
MeSH terms: Africa, Eflornithine, Animals, Communicable Disease Control, Humans, Insect Bites and Stings, Insect Vectors, Melarsoprol, Pentamidine, Suramin, Trypanocidal Agents, Trypanosoma brucei gambiense, Trypanosomiasis, African, Tsetse Flies, Variant Surface Glycoproteins, Trypanosoma, Incidence, Endemic Diseases, Biomedical Research

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Human African trypanosomiasis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks